Used in genetic screening research to identify individuals carrying the HLA-B*15:02 allele, which is strongly associated with an increased risk of developing severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), when exposed to certain antiepileptic drugs like carbamazepine. The ELISA research kit enables rapid, sensitive, and specific detection of HLA-B*15:02 in human serum or plasma samples, supporting pharmacogenetic studies and helping guide safer drug prescribing practices, particularly in populations with higher allele frequency, such as Southeast Asian descent. It is a valuable tool in personalized medicine and drug safety research.